Reorganization of Innate Immune Cell Lipid Profiles by Bioinspired Meroterpenoids to Limit Inflammation
Advanced Science · 2026
DOI: 10.1002/advs.76861 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, 2026. Verfasst von Lorenz Waltl und 20 weiteren Autor:innen. Beteiligte Einrichtung: Michael Popp Institute and Center for Molecular Biosciences (CMBI), University of Innsbruck, Innsbruck, Austria. Hauptthemen laut MEDLINE: Lipid Metabolism, Inflammation, Terpenes, Immunity, Innate. Die Arbeit nennt 193 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Austrian Science Fund, European Research Council under the European Union's Horizon 2020 research and innovation program, Center for Molecular Biosciences.
Abstract (Originalsprache)
Lipidomics‐guided screening of unexplored natural product chemical space provides access to small molecules that globally reprogram cellular lipid profiles. Here, we show that the meroterpenoid cyclosmenospongine from Spongia sp . reshapes immune cell lipidomes, shifting them from pro‐inflammatory toward anti‐inflammatory and pro‐resolving mediators. Structural variation yielded derivatives that context‐dependently inhibit leukotriene biosynthesis to varying extents while upregulating pro‐resolving lipid mediators, epoxyeicosatrienoic acids, endocannabinoids, sphingosine‐1‐phosphate, and others in resting and activated innate immune cells in vitro, as well as in self‐resolving murine peritonitis and fibrosis in vivo. Mechanistically, meroterpenoids target 5‐lipoxygenase or 5‐lipoxygenase‐activating protein, promote 15‐lipoxygenase‐1 translocation to particulate sites, and inhibit monoacylglycerol lipase. They also redirect arachidonic acid from neutral lipids to specific phospholipids while increasing free arachidonic acid levels. Furthermore, meroterpenoids reprogram immune cell lipid metabolism by reducing neutral lipid, triacylglycerol, and cholesteryl ester levels, a shift that correlates with a lower capacity for leukotriene biosynthesis and is phenocopied by inhibiting sterol‐O‐acyltransferase, which catalyzes cholesterol esterification for storage, and diacylglycerol acyltransferase‐1/2, which catalyze the final step in triacylglycerol biosynthesis. In conclusion, specific meroterpenoids exert anti‐inflammatory effects by rewiring lipid mediator biosynthesis through structure‐controlled switches in lipid mediator classes, and an unexpected link between lipogenesis and inflammation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Michael Popp Institute and Center for Molecular Biosciences (CMBI), University of Innsbruck, Innsbruck, Austria.
- Institute of Human Genetics, Medical University of Innsbruck, Innsbruck, Austria.
- Institute of Pharmaceutical Sciences and Excellence Field BioHealth, NAWI Graz, University of Graz., Graz, Austria.
- Department of Organic Chemistry and Center for Molecular Biosciences (CMBI), University of Innsbruck, Innsbruck, Austria.
- Department of Pharmacy, School of Medicine and Surgery, University of Naples Federico II, Naples, Italy.
- Clinical Department of Blood Group Serology and Transfusion Medicine, Medical University of Graz, Graz, Austria.
ORCID-Profile: Lorenz Waltl, David Holubek, Franz-Lucas Haut, Stephan Permann, Immanuel Plangger, Zhigang Rao, Danilo D'Avino, Ida Cerqua, Fiorentina Roviezzo, Anita Siller, Harald Schennach, Solveigh C Koeberle, Eva-Maria Pferschy-Wenzig, Antonietta Rossi, Thomas Magauer, Andreas Koeberle
Förderung
- Austrian Science Fund
- European Research Council under the European Union's Horizon 2020 research and innovation program
- Center for Molecular Biosciences
- Ministero dell'Università e della Ricerca
Zitieren
APA
Waltl, L., Holubek, D., Speck, K., Wildermuth, R., Haut, F. L., Permann, S., Plangger, I., Steinborn, C., Rao, Z., D'Avino, D., Cerqua, I., Stadler, J., Roviezzo, F., Schlenke, P., Siller, A., Schennach, H., Koeberle, S. C., Pferschy-Wenzig, E. M., Rossi, A., …, & Koeberle, A. (2026). Reorganization of Innate Immune Cell Lipid Profiles by Bioinspired Meroterpenoids to Limit Inflammation. Advanced Science. https://doi.org/10.1002/advs.76861
Vancouver
Waltl L, Holubek D, Speck K, Wildermuth R, Haut FL, Permann S, et al. Reorganization of Innate Immune Cell Lipid Profiles by Bioinspired Meroterpenoids to Limit Inflammation. Advanced Science. 2026. doi:10.1002/advs.76861
BibTeX
@article{Waltl2026,
author = {Waltl, Lorenz and Holubek, David and Speck, Klaus and Wildermuth, Raphael and Haut, Franz-Lucas and Permann, Stephan and Plangger, Immanuel and Steinborn, Christian and Rao, Zhigang and D'Avino, Danilo and Cerqua, Ida and Stadler, Julia and Roviezzo, Fiorentina and Schlenke, Peter and Siller, Anita and Schennach, Harald and Koeberle, Solveigh C and Pferschy-Wenzig, Eva-Maria and Rossi, Antonietta and Magauer, Thomas and Koeberle, Andreas},
title = {Reorganization of Innate Immune Cell Lipid Profiles by Bioinspired Meroterpenoids to Limit Inflammation},
journal = {Advanced Science},
year = {2026},
doi = {10.1002/advs.76861}
}
EUVIMED